A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/15/2018 |
| Start Date: | May 21, 2012 |
| End Date: | July 23, 2013 |
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
This study is a 1-year open label extension study to collect long term efficacy and safety
data from patients who have completed approximately 2 years of dosing in Study CL0600-021.
data from patients who have completed approximately 2 years of dosing in Study CL0600-021.
This study served as a 1-year extension study for those US patients who have completed the
CL0600-021 study.
CL0600-021 study.
Inclusion Criteria:
- At completion of Study CL0600-021, subjects will be invited to participate in this
trial if they meet the following criteria:
1. Completion of the 24-month study, CL0600-021, regardless if fully weaned from
PN/I.V. support
2. Signed and dated informed consent form (ICF) to participate before any
study-related procedures of Study TED-C11-001 are performed
Exclusion Criteria:
We found this trial at
5
sites
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials
Emory University School of Medicine Emory University School of Medicine has 2,359 full- and part-time...
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
Mount Sinai Med Ctr Founded in 1852, The Mount Sinai Hospital is a 1,171-bed, tertiary-care...
Click here to add this to my saved trials
Click here to add this to my saved trials